A randomized, open-label, parallel-group, 6 week treatment, multi-center, phase III study to investigate the efficacy and safety of 100 microg and 200 microg twice daily of budesonide turbuhaler and 50 microg and 100 microg twice daily of fluticasone Diskus in Japanese children with bronchial asthma aged 5-15

Trial Profile

A randomized, open-label, parallel-group, 6 week treatment, multi-center, phase III study to investigate the efficacy and safety of 100 microg and 200 microg twice daily of budesonide turbuhaler and 50 microg and 100 microg twice daily of fluticasone Diskus in Japanese children with bronchial asthma aged 5-15

Completed
Phase of Trial: Phase III

Latest Information Update: 17 Dec 2016

At a glance

  • Drugs Budesonide; Fluticasone propionate
  • Indications Asthma
  • Focus Therapeutic Use
  • Sponsors AstraZeneca
  • Most Recent Events

    • 16 May 2010 Results were presented at the 106th International Conference of the American Thoracic Society.
    • 18 Dec 2007 Status change from in progress to completed.
    • 10 Aug 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top